The generation of CAR T cells out of blood products harboring a higher frequency of memory CD8+ T cells (CD8+CD45RO−CD27+) and a higher CD4+/CD8+ ratio was associated with better in vivo expansion and clinical response in multiple myeloma patients [105]. The gene discussed is CD8A; the disease is plasma cell myeloma.